Clinical Trial Update: Multiple Ascending Dose Study of NH102 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of NH102 in healthy subjects has completed, with depression listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NH102

Snippet

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Conditions: Depression | Phase 1 | Status: COMPLETED